Hadron Therapy Workshop: status and perspectives, plans for next generation facilities 18-19 October 2024

from Friday 18 October 2024 (08:00) to Saturday 19 October 2024 (23:30)
Zoom

        : Sessions
    /     : Talks
        : Breaks
18 Oct 2024
19 Oct 2024
AM
08:00
SESSION 1 - HADRON THERAPY OVERVIEW (until 11:30) ()
08:00 Participants registration   ()
08:45 Welcome Addresses   ()
09:15 Historic and scientific evolution of Hadron Therapy - Sandro Rossi (CNAO) Ugo Amaldi (TERA Foundation (IT))   ()
09:35 Hadron Therapy in clinical practice - Sara Lillo (CNAO)   ()
09:55 Radiobiology of Hadron Therapy - Angelica Facoetti (CNAO)   ()
10:15 HITRIplus project, its impact on boosting research in South East Europe and future perspectives - Sanja Damjanovic (SEEIIST Association (CH) / GSI)   ()
10:35 Building capacity through the IAEA programs - Sotirios Charisopoulos (IAEA)   ()
10:55 --- Coffee Break ---
11:30
SESSION 2 – HADRON THERAPY DEVELOPMENTS AND FUTURE PERSPECTIVES (until 15:00) ()
11:30 Hadron Therapy : from pioneering times towards the future - Manjit Dosanjh (University of Oxford (GB))   ()
11:50 SEEIIST facility design and alternatives - Maurizio Vretenar (CERN)   ()
12:10 CERN as an example of large scale infrastructure - Emmanuel Tsesmelis (CERN)   ()
12:30 Status and vision of the SEEIIST project - Leandar Litov (University of Sofia - St. Kliment Ohridski (BG))   ()
12:50 Concluding remarks - Roberto Orecchia (IEO)   ()
13:00 Round table – SEEIIST towards to the Future   ()
13:45 --- Lunch Break ---
09:00
Session 5 – INDICATIONS FOR HADRON THERAPY (until 11:30) ()
09:00 Chordoma treatments at CNAO - Maria Rosaria Fiore (CNAO)   ()
09:25 Sarcoma treatments in Greece - Tasos Kyriazoglou (Attikon University Hospital)   ()
09:45 Radiosurgery for Skullbase Meningiom - Christos Boskos (ST. LUKE'S)   ()
10:05 SRS Treatment Planning for Endocranial Tumor - Anna Makridou   ()
10:25 Personalization of hadron therapy for radioresistant cancers through bioindicators of radioresistance or conditional vulnerability - Michael Story (Mayo Clinic)   ()
10:50 Concluding remarks - Arnold Pompos (UT Southwestern, Dallas, TX) Joao Seco (DKFZ)   ()
11:05 --- Coffee Break ---
11:30
SESSION 6 – SOCIO-ECONOMIC ASPECTS RELATED TO HADRON THERAPY - Sandro Rossi (Fondazione CNAO) (until 15:00) ()
11:30 Hadrontherapy and EU clinical networks: status and perspectives - Lisa Licitra (CNAO, Uni Milan)   ()
11:50 Costs of hadrontherapy, the ABC analysis applied to operations in CNAO - Maria Vittoria Livraga (CNAO)   ()
12:10 Caring for cancer patients: the CNAO social approach - Silvia Meneghello (CNAO)   ()
12:30 The role of citizens in innovating health - Katerina Zourou (Web2Learn) Stefania Oikonomou (Web2Learn)   ()
12:45 The role of biomedical and clinical engineering societies in advancing and promoting Hadron Therapy on a national and international level - Alkinoos Athanasiou (AUTH, ELEVIT)   ()
13:00 Challenges and Opportunities in the Patient's Pathway to Access - Menia Koukougianni (NGO KARKINAKI)   ()
13:20 Empowering patient advocacy and cancer prevention - Panagiotis Bamidis (AUTH/AHEPA, ELEVIT)   ()
13:35 Concluding remarks - Sandro Rossi (CNAO)   ()
13:40 --- Lunch Break ---
PM
15:00
SESSION 3 – EXPERIENCES OF MULTIPARTICLE THERAPY FACILITIES IN OPERATION IN EUROPE (until 17:00) ()
15:00 Hadron Therapy at GSI - where we come from, where we go - Konrad Lehmann (GSI)   ()
15:25 The HIT facility, technology, clinical applications and research: novel approaches in particle therapy - Andrea Mairani (HIT)   ()
15:50 The Krakow Hadron Therapy facility, lessons learnt - Pawel Olko (IFJ - PAN)   ()
16:15 Concluding remarks - Angelica Facoetti (CNAO)   ()
16:30 --- Coffee Break ---
17:00
SESSION 4 – ADVANCES IN ACCELERATOR TECHNOLOGIES FOR HADRON THERAPY FACILITIES (until 22:20) ()
17:00 Accelerator and beam physics developments for medical and societal applications at CERN - Alessandra Lombardi (CERN)   ()
17:20 Innovative gantry designs: Superconducting magnets for advanced gantry - Ernesto De Matteis (INFN)   ()
17:35 Innovative gantry designs-continued - Ariel Haziot (CERN)   ()
17:50 Optimisation for pre-injectors for hadron therapy-AM - Aristeidis Mamaras (Aristotle University of Thessaloniki / CERN)   ()
18:10 An ion source project as a seed to build capacity for next generation accelerator physicists in Bosnia-and-Herzegovina - Medina Dugonjic (UNSA) Naida Ustavdic (UNSA) Danis Bradaric (UNSA) Amer Ajanovic (CERN/UNSA)   ()
18:25 Development of the first table-top X-ray FLASH system - Joao Seco (DKFZ) Ms ELPIDA THEODORIDOU (DKFZ / Uni Malta)   ()
18:40 Concluding remarks - Laura Vallow (Mayo Clinic)   ()
20:00 Welcome, Music event and Welcome Drink   ()
15:00
SESSION 7 – PEDIATRIC ONCOLOGY AND ROLE OF HADRON THERAPY (until 18:45) ()
15:00 Carbon Programme in MedAustron - Piero Fossati (MedAustron)   ()
15:15 Pediatric Treatments in MedAustron - Carola Lütgendorf-Caucig (MedAustron)   ()
15:30 Hadron therapy state-of-the art in pediatric oncology-clinical aspects - Sabina Vennarini (CNAO)   ()
15:45 Treatment planning for pediatric cancer tumour treatments - Alfredo Mirandola (CNAO)   ()
16:00 Pediatric brain tumour surgery : where do we stand? - Nikos Foroglou (AUTH/AHEPA)   ()
16:15 Role of surgery in pediatric soft tissue sarcoma - Aikaterini Tzantzaroudi (Hippokration Hospital)   ()
16:30 --- Coffee Break ---
17:00 Panel discussion: Paediatric Oncology in Greece   ()
17:01 Clinical profile of pediatric oncology patients managed and treated in Pediatric Haematology and/or Oncology Unit University Hospital AHEPA - Emmanouel Chatzipantelis (AUTH/AHEPA)   ()
17:15 Clinical profile of pediatric oncology patients managed and treated in Pediatric Haematology and/or Oncology Unit Hospital Hippoktateio Hospital - Evgenia Papakonstantinou (Hippokrateio Hospital)   ()
17:30 Pediatric patients commonly referred for external beam Radiotherapy - Eftychia Tataridou (Theageneio Hospital) Antonio Capizzello (AUTH / AHEPA)   ()
17:45 The spectrum of pediatric patients referred for Protontherapy - Barbara Rombi (APSS - TRENTO)   ()
18:00 Radiation treatment plan for pediatric cancer: a clinical view - George Giakoumetis (AUTH/AHEPA)   ()
18:15 Concluding remarks - Semi Harrabi (HIT)   ()